Ladenburg Thalmann Financial Services’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-197
| Closed | -$5K | – | 5378 |
|
|
2018
Q2 | $5K | Hold |
197
| – | – | ﹤0.01% | 4614 |
|
|
2018
Q1 | $5K | Sell |
197
-68
| -26% | -$1.73K | ﹤0.01% | 4614 |
|
|
2017
Q4 | $7K | Buy |
+265
| New | +$7K | ﹤0.01% | 4401 |
|
|
2017
Q1 | – | Sell |
-142
| Closed | -$1K | – | 5010 |
|
|
2016
Q4 | $1K | Hold |
142
| – | – | ﹤0.01% | 4738 |
|
|
2016
Q3 | $1K | Hold |
142
| – | – | ﹤0.01% | 4686 |
|
|
2016
Q2 | $2K | Sell |
142
-7,390
| -98% | -$104K | ﹤0.01% | 4455 |
|
|
2016
Q1 | $103K | Hold |
7,532
| – | – | ﹤0.01% | 2046 |
|
|
2015
Q4 | $143K | Sell |
7,532
-373
| -5% | -$7.08K | ﹤0.01% | 1808 |
|
|
2015
Q3 | $148K | Buy |
7,905
+7,195
| +1,013% | +$135K | ﹤0.01% | 1713 |
|
|
2015
Q2 | $11K | Buy |
+710
| New | +$11K | ﹤0.01% | 3644 |
|